Filing Details
- Accession Number:
- 0001562180-23-002201
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-03 08:01:34
- Reporting Period:
- 2023-03-01
- Accepted Time:
- 2023-03-03 08:01:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1517022 | Akebia Therapeutics Inc. | AKBA | Pharmaceutical Preparations (2834) | 208756903 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591467 | P. John Butler | C/O Akebia Therapeutics, Inc. 245 First Street Cambridge MA 02142 | Ceo And President | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-01 | 38,259 | $0.88 | 1,622,481 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-01 | 47,239 | $0.88 | 1,575,242 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-01 | 6,370 | $0.88 | 1,568,872 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 100,000 | Indirect | Held By John Butler GRAT November 2019 |
| Common Stock | 59,928 | Indirect | Held by John Butler 2019 GRAT |
| Common Stock | 100,000 | Indirect | Held By Dorothy Butler GRAT November 2019 |
| Common Stock | 59,928 | Indirect | Held by Dorothy Butler 2019 GRAT |
Footnotes
- This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.
- This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.
- This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.
Billionaire Hedge Funds
